Provectus Biopharmaceuticals, Inc. Financial Ratios — PVCT

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-140.06	-128.55	-211.33	-44.35	-105.11	-187.54	-298.82	-300.59	-399.55	-646.39	-270.05	-128.08	-177.95	-387.94	-646.23
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	1.26	1.44	4.01	- -	- -	8.9	0.1	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	9	14	21	24	2	2	3	3	3
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	24	2	2	3	3	3
LT Debt	- -	- -	- -	- -	- -	- -	9	14	20	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-0.75	-1.89	-3.67	-5.04	-0.37	-0.64	-1.04	-0.7	-0.56
Net Debt/EBITDA	0.37	0.09	1.27	1.08	0.59	0.05	-0.74	-1.88	-3.53	-5	-0.22	-0.6	-0.99	-0.63	-0.49
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-0.71	-1.73	-3.27	-4.8	-0.37	-0.64	-1.03	-0.7	-0.56
Net Debt/EBIT	0.36	0.09	1.2	1.03	0.58	0.05	-0.7	-1.72	-3.14	-4.75	-0.22	-0.6	-0.98	-0.63	-0.49
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-31.46	-7.6	-3.86	-2.7	-4.84	-20.88	-13.49	-18.92	-25.16
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-31.53	-7.6	-3.86	-2.7	-4.84	-20.88	-13.49	-18.92	-25.16
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-33.17	-8.31	-4.33	-2.84	-4.85	-20.94	-13.53	-18.95	-25.17
Interest Expense	- -	- -	- -	- -	- -	- -	- -	1	1	2	1	- -	- -	- -	- -
Common Equity/Total Assets	-791.57	-1,905.63	-729.16	-596.2	-883.53	-3,651.01	-6,354.63	-11,392.56	-15,805.15	-40,749.35	-6,990.88	-12,230.69	-17,411.89	-25,540.41	-37,624.77
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-4.53	-6.55	-9.3	-0.04	- -	-0.03	-0.01	- -	-0.04
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	275.17	700.73	1,340.48	14.23	- -	3.6	1.75	- -	14.74
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	-94.38	-79.99	-85.59	-78.78	-41.65	-35.08	-39.85	-53.35	-47.26
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-4.53	-6.55	-9.68	-11	-0.72	-0.88	-1.21	-1.25	-1.15
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	275.17	700.73	1,394.98	4,038.77	49.64	107.24	208.87	316.5	427.05
Net Debt to Equity	-76.91	-27.81	-236.79	-69.04	-86.9	-33.6	-93.33	-79.7	-82.27	-78.03	-24.25	-32.84	-37.88	-47.78	-41.25
Net Debt/Capital (%)	6.8	1.02	9.71	10.02	7.28	0.57	-4.47	-6.53	-9.28	-10.89	-0.42	-0.83	-1.15	-1.12	-1
EBITDA	-21	-14	-12	-16	-24	-24	-13	-7	-6	-5	-5	-3	-3	-5	-5
EBITDA-CapEx	-21	-14	-12	-16	-24	-24	-13	-7	-6	-5	-5	-3	-3	-5	-5
Operating Income (Loss)	-21	-14	-13	-17	-25	-25	-13	-8	-6	-5	-5	-3	-3	-5	-5

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	29.33	2.39	30.6	20.52	3.44	0.54	0.03	0.01	0.2	- -	0.09	- -	0.01	0.04	0.04
Current Ratio	29.33	2.39	30.6	22.53	3.57	0.85	0.27	0.25	0.33	0.01	0.45	0.23	0.15	0.14	0.08
Quick Ratio	29.33	2.39	30.6	21.38	3.56	0.68	0.16	0.16	0.21	- -	0.09	- -	0.01	0.04	0.04
CFO/Avg Current Liab	-21.34	-29.09	-19.31	-20.35	-7.01	-7	-3.61	-1.35	-1.74	-0.24	-0.05	-0.38	-0.3	-0.41	-0.48
Common Equity/Total Assets	-791.57	-1,905.63	-729.16	-596.2	-883.53	-3,651.01	-6,354.63	-11,392.56	-15,805.15	-40,749.35	-6,990.88	-12,230.69	-17,411.89	-25,540.41	-37,624.77
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-4.53	-6.55	-9.3	-0.04	- -	-0.03	-0.01	- -	-0.04
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	275.17	700.73	1,340.48	14.23	- -	3.6	1.75	- -	14.74
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	-94.38	-79.99	-85.59	-78.78	-41.65	-35.08	-39.85	-53.35	-47.26
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-4.53	-6.55	-9.68	-11	-0.72	-0.88	-1.21	-1.25	-1.15
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	275.17	700.73	1,394.98	4,038.77	49.64	107.24	208.87	316.5	427.05
CFO/Total Liabilities	-516.52	-621.69	-73.94	-1,392.7	-422.28	-1,024.21	-76.91	-26.82	-24.23	-13.27	-13.16	-36.8	-28.44	-47.08	-47.51
CFO/CapEx	- -	- -	- -	- -	- -	- -	-340.41	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-11.65	-144.97	-0.29	73.72	-7.25	-108.5	-188.01	-318.91	-280.15	-660.46	-102.13	-177.48	-254.5	-375.83	-561.52

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	86	63	318	141	76	5	30	19	24	23	22	45	40	50	23
- Cash & Cash Equivalents	8	1	16	17	14	1	- -	- -	1	- -	1	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	9	14	21	24	2	2	3	3	3
Enterprise Value	78	62	302	123	62	4	40	33	44	47	24	48	43	53	26
Total Capital	-106	-118	-146	-156	-181	-205	-209	-213	-213	-216	-244	-247	-249	-254	-259
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-4.53	-6.55	-9.68	-11	-0.72	-0.88	-1.21	-1.25	-1.15
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.24	0.42	0.46	0.51	0.07	0.05	0.07	0.06	0.11
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	86	63	318	141	76	5	30	19	24	23	22	45	40	50	23
Diluted Enterprise Value	78	62	302	123	62	4	40	33	44	47	24	48	43	53	26
EV per Share	0.74	0.55	2.29	0.7	0.32	0.02	0.11	0.09	0.11	0.12	0.06	0.11	0.1	0.13	0.06
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-21	-14	-12	-16	-24	-24	-13	-7	-6	-5	-5	-3	-3	-5	-5
TTM Operating Income	-21	-14	-13	-17	-25	-25	-13	-8	-6	-5	-5	-3	-3	-5	-5
TTM Cash Flow to Firm	-17	-11	-10	-14	-17	-22	-10	-4	-5	-2	- -	-3	-2	-3	-3
TTM Free Cash Flow to Firm	-17	-11	-10	-14	-17	-22	-10	-4	-5	-2	- -	-3	-2	-3	-3

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-4.98	-5.62	-32.16	-10.16	-4.38	-0.21	-2.93	-3.67	-3.93	-5.58	-22.16	-14.94	-15.66	-15.35	-7.06
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	78	62	302	123	62	4	40	33	44	47	24	48	43	53	26
Low Price	0.67	0.43	0.55	0.46	0.32	0.01	0.02	0.03	0.01	0.03	0.04	0.03	0.06	0.04	0.05
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-5.03	-6.8	-3.55	-25.19	-5.22	-2.28	-0.94	-3.35	-3.37	-3.61	-4.8	-7.53	-16.27	-11.87	-6.47
Price/Earnings High	-6.61	-9.22	-11.84	-103.51	-7.91	-4.69	-2.26	-4.31	-4.19	-7.66	-6.63	-22.42	-23.65	-19.79	-9.24
Price/Earnings Low	-3.6	-3.82	-2.51	-7.94	-2.56	-0.1	-0.41	-1.41	-0.61	-1.77	-3.1	-4.01	-7.57	-3.92	-3.82
Price/Book Value	-0.81	-0.54	-2.18	-0.9	-0.42	-0.02	-0.14	-0.08	-0.1	-0.09	-0.09	-0.18	-0.16	-0.2	-0.09
Price/Book Value Average	-0.94	-0.73	-0.7	-1.65	-0.71	-0.3	-0.06	-0.12	-0.1	-0.1	-0.11	-0.11	-0.2	-0.22	-0.14
Price/Book Value High	-1.23	-0.99	-2.34	-6.79	-1.07	-0.61	-0.14	-0.16	-0.12	-0.21	-0.15	-0.32	-0.29	-0.37	-0.19
Price/Book Value Low	-0.67	-0.41	-0.5	-0.52	-0.35	-0.01	-0.03	-0.05	-0.02	-0.05	-0.07	-0.06	-0.09	-0.07	-0.08
Price/Tangible Book Value	19.38	-118.28	134.01	6.51	5.69	3.81	-2.61	-1.04	-1	-0.76	-5.33	-7.27	-5.29	-8.43	-3.72
Price/Tangible Book Value Average	22.39	-162.02	43.22	11.94	9.54	49.87	-1.1	-1.49	-0.96	-0.8	-6.32	-4.28	-6.63	-9.45	-5.64
Price/Tangible Book Value High	29.43	-219.66	144.02	49.07	14.45	102.46	-2.64	-1.92	-1.19	-1.69	-8.73	-12.75	-9.63	-15.75	-8.05
Price/Tangible Book Value Low	16.03	-91.03	30.58	3.76	4.69	2.1	-0.48	-0.63	-0.17	-0.39	-4.07	-2.28	-3.08	-3.12	-3.33
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-4.98	-5.62	-32.16	-10.16	-4.38	-0.21	-2.93	-3.67	-3.93	-5.58	-22.16	-14.94	-15.66	-15.35	-7.06
Price/Cash Flow Average	-5.75	-7.7	-10.37	-18.63	-7.35	-2.79	-1.23	-5.25	-3.77	-5.91	-26.24	-8.8	-19.62	-17.21	-10.71
Price/Cash Flow High	-7.56	-10.44	-34.56	-76.57	-11.13	-5.73	-2.96	-6.76	-4.68	-12.51	-36.26	-26.2	-28.53	-28.7	-15.29
Price/Cash Flow Low	-4.12	-4.33	-7.34	-5.87	-3.61	-0.12	-0.54	-2.2	-0.69	-2.89	-16.92	-4.69	-9.13	-5.69	-6.32
Price/Free Cash Flow Average	-5.75	-7.7	-10.37	-18.63	-7.35	-2.79	-1.24	-5.25	-3.77	-5.91	-26.24	-8.8	-19.62	-17.21	-10.71
Price/Free Cash Flow High	-7.56	-10.44	-34.56	-76.57	-11.13	-5.73	-2.97	-6.76	-4.68	-12.51	-36.26	-26.2	-28.53	-28.7	-15.29
Price/Free Cash Flow Low	-4.12	-4.33	-7.34	-5.87	-3.61	-0.12	-0.54	-2.2	-0.69	-2.89	-16.92	-4.69	-9.13	-5.69	-6.32
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-4.4	-6.26	-7.04	-14.92	-4.75	-2.48	-1.75	-5.59	-7.72	-10.14	-5.95	-8.47	-18.32	-13.13	-7.25
EV/EBITDA High	-5.89	-8.51	-26.41	-64.65	-7.49	-5.14	-3.17	-6.66	-8.73	-15.86	-8.13	-23.96	-26.18	-21.47	-10.13
EV/EBITDA Low	-3.04	-3.48	-4.61	-3.96	-2.03	-0.06	-1.18	-3.44	-4.32	-7.52	-3.92	-4.81	-9.07	-4.77	-4.49
EV/EBIT Average	-4.26	-5.96	-6.67	-14.31	-4.61	-2.41	-1.66	-5.11	-6.88	-9.64	-5.93	-8.44	-18.27	-13.11	-7.25
EV/EBIT High	-5.71	-8.11	-25.04	-62.03	-7.28	-5	-3	-6.09	-7.78	-15.09	-8.1	-23.88	-26.1	-21.43	-10.12
EV/EBIT Low	-2.94	-3.31	-4.37	-3.8	-1.97	-0.06	-1.12	-3.15	-3.85	-7.16	-3.91	-4.8	-9.05	-4.76	-4.49
Last Price	0.81	0.56	2.41	0.8	0.39	0.02	0.08	0.05	0.06	0.06	0.06	0.11	0.1	0.12	0.06
High Price	1.23	1.04	2.59	6.03	0.99	0.54	0.08	0.09	0.08	0.13	0.09	0.19	0.17	0.22	0.12
Enterprise Value Average	91	85	87	241	114	60	22	41	43	48	28	29	53	59	38
Enterprise Value High	122	116	326	1,043	180	125	40	49	49	75	38	82	76	97	54
Enterprise Value Low	63	47	57	64	49	1	15	25	24	35	18	16	26	22	24

Shares Outstanding	111	118	160	185	205	365	371	385	390	399	419	419	420	420	420
Diluted Weighted Avg Shares	106	113	132	176	196	234	369	382	387	393	408	419	420	420	420
Basic Weighted Avg Shares	106	113	132	176	196	234	369	382	387	393	408	419	420	420	420
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.2	-0.12	-0.09	-0.09	-0.12	-0.1	-0.03	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Operating Income per Share	-0.2	-0.13	-0.1	-0.1	-0.13	-0.11	-0.04	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Basic EPS, GAAP	-0.19	-0.11	-0.22	-0.06	-0.13	-0.11	-0.04	-0.02	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01
Basic EPS from Cont Ops	-0.18	-0.11	-0.21	-0.06	-0.13	-0.1	-0.04	-0.02	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01
Diluted EPS, GAAP	-0.19	-0.11	-0.22	-0.06	-0.13	-0.11	-0.04	-0.02	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01
Diluted EPS from Cont Ops	-0.18	-0.11	-0.21	-0.06	-0.13	-0.1	-0.04	-0.02	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.16	-0.1	-0.07	-0.08	-0.09	-0.09	-0.03	-0.01	-0.02	-0.01	- -	-0.01	-0.01	-0.01	-0.01
Free Cash Flow per Basic Share	-0.16	-0.1	-0.07	-0.08	-0.09	-0.09	-0.03	-0.01	-0.02	-0.01	- -	-0.01	-0.01	-0.01	-0.01
Cash & Equivalents per Share	0.07	0.01	0.12	0.1	0.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-1	-1.05	-1.11	-0.89	-0.92	-0.88	-0.59	-0.59	-0.6	-0.61	-0.6	-0.59	-0.6	-0.61	-0.62
Tangible Book Value per Share	0.04	- -	0.02	0.12	0.07	0.01	-0.03	-0.05	-0.06	-0.08	-0.01	-0.01	-0.02	-0.01	-0.02

Provectus Biopharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)